MedTrace Logo

A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

NCT05794217 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-12-06

No results posted yet for this study

Summary

To collect, preserve, and distribute annotated leukopak biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.

This protocol will be utilized to collect research grade products that are not meant for transfusion.

Conditions

Interventions

BEHAVIORAL

This is a non-interventional study

This is a non-interventional study

Sponsors & Collaborators

  • Sanguine Biosciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-28
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05794217 on ClinicalTrials.gov